Mifepristone and misoprostol for medical termination of pregnancy: The effectiveness of a flexible regimen

Journal of Family Planning and Reproductive Health Care

Volumn 29, Issue 3, 2003, Pages 139-141

  Basu, Ranjan ^a   Gundlach, Tina ^a   Tasker, Margaret ^a  

^a ROYAL BOLTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ABORTION; ADOLESCENT; ADULT; ARTICLE; CLINICAL PRACTICE; CONTRACEPTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; PREGNANCY; THERAPEUTIC ABORTION; TREATMENT PLANNING;

EID: 0038713790     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118903101197818     Document Type: Article

References (7)

1. UK Multicentre Study: final results. The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days' gestation. Contraception 1997; 55: 1-5.
2. Gouk EV, Lincoln K, Khair A, et al. Medical termination of pregnancy at 63 to 83 days' gestation. Br J Obstet Gynaecol 1999; 106: 535-553.
3. Ashok PW, Templeton A. Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases. Br J Obstet Gynaecol 1999; 106: 706-710.
4. Schaff EA, Fielding SL, Westhoff C, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial. JAMA 2000; 284: 1948-1953.
5. Creinin MD, Schwaretz HC, Pymar HC, et al. Efficacy of mifepristone followed on the same day by misoprostol for early termination of pregnancy: report of a randomized trial. Br J Obstet Gynaecol 2001; 108: 469-473.
6. Ashok PW, Templeton A, Wagaarachchi PT, et al. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. Br J Obstet Gynaecol 2002; 109: 1281-1289.
7. El Refaey H, Rajasekar D, Abdalla M, et al. Induction of abortion with mifepristone (RU486) and oral or vaginal misoprostol. N Engl J Med 1995; 332: 983-987.